Outpatient procedures are growing, Pharma and Medtech need to adapt
Updated: Mar 24, 2020
Routine procedures are moving from hospital to outpatient setting, providing lower costs, reduced infections and improved outcomes.
Pharma and MedTech companies need to understand and seize this opportunity.
Outpatient setting also allows hospital to "outsource" simple, repetitive procedures, thereby reducing their budget. Outpatient treatments often benefit from faster, simpler adoption, outside complex hospital formularies.
Pharma and MedTech need to optimize go-to-market strategy and structures to this growing trend.